Data / Drug companies / Insight Pharmaceuticals LLC
Insight Pharmaceuticals LLC: 29 products in the FDA NDC directory, labeler code 63736
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Insight Pharmaceuticals LLC (labeler code 63736) lists 29 products in the FDA National Drug Code Directory, covering 17 finished drugs by generic name. By type: 29 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on March 1, 2025.
The request: Watch Insight Pharmaceuticals LLC (FDA labeler code 63736): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 63736
- Products in commercial distribution
- 29
- Packages
- 33
- Finished drugs by generic name
- 17
- Prescription products
- 0
- Over the counter products
- 29
- Flagged as original packager
- 26 of 26 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 2
- Earliest marketing start
- April 26, 1993
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 17 | 58.6% |
| New drug applications (NDA) | 10 | 34.5% |
| Other unapproved drugs | 1 | 3.4% |
| Generic drugs (ANDA) | 1 | 3.4% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 29 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Miconazole nitrate | 8 | 101 |
| Benzocaine | 4 | 110 |
| Permethrin | 2 | 12 |
| Hydrocortisone | 2 | 171 |
| Oxymetazoline hydrochloride | 1 | 64 |
| Phenazopyridine hydrochloride | 1 | 53 |
| Salicylic acid | 1 | 330 |
| Cornstarch and zinc oxide | 1 | 1 |
| Tioconazole | 1 | 16 |
| Asprin and caffeine | 1 | 1 |
| Dyclonine hcl, menthol, and pectin | 1 | 1 |
| Dyclonine hydrochloride | 1 | 2 |
| Dyclonine hydrochloride and menthol | 1 | 1 |
| Mineral oil and petrolatum | 1 | 2 |
| Starch, corn and zinc oxide | 1 | 1 |
| Dimethicone | 1 | 69 |
| Isopropyl alcohol | 1 | 177 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Kit | 6 | 20.7% |
| Cream | 4 | 13.8% |
| Ointment | 3 | 10.3% |
| Lozenge | 3 | 10.3% |
| Tablet | 2 | 6.9% |
| Liquid | 2 | 6.9% |
| Powder | 2 | 6.9% |
| Gel | 2 | 6.9% |
| Spray | 1 | 3.4% |
| Spray, metered | 1 | 3.4% |
| Aerosol, spray | 1 | 3.4% |
| Lotion | 1 | 3.4% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Monistat Maintain | 63736-020 | Tablet | Other unapproved drugs | March 1, 2025 |
| Monistat Care Instant Itch Relief | 63736-050 | Spray | Over the counter monograph drugs | October 1, 2017 |
| Caldesene Medicated Protecting | 63736-306 | Powder | Over the counter monograph drugs | July 15, 2017 |
| Sucrets | 63736-567 | Lozenge | Over the counter monograph drugs | November 4, 2014 |
| Nix Complete Lice Treatment | 63736-035 | Kit | New drug applications (NDA) | November 15, 2013 |
| Monistat Complete Care Chafing Relief | 63736-031 | Gel | Over the counter monograph drugs | November 15, 2013 |
| Nix | 63736-030 | Rinse | New drug applications (NDA) | November 15, 2013 |
| Monistat Complete Care Instant Itch Relief | 63736-029 | Cream | Over the counter monograph drugs | November 15, 2013 |
| Dermarest Eczema Medicated | 63736-339 | Lotion | Over the counter monograph drugs | September 20, 2010 |
| Dermarest Psoriasis Medicated | 63736-302 | Liquid | Over the counter monograph drugs | July 23, 2010 |
| Boil Ease | 63736-040 | Ointment | Over the counter monograph drugs | June 21, 2010 |
| Stye | 63736-238 | Gel | Over the counter monograph drugs | June 15, 2010 |
| Auro Dri | 63736-327 | Liquid | Over the counter monograph drugs | June 14, 2010 |
| Monistat 3 Combination Pack | 63736-010 | Kit | New drug applications (NDA) | December 10, 2009 |
| Sucrets vapor cherry | 63736-925 | Lozenge | Over the counter monograph drugs | July 28, 2009 |
| Sucrets Sore Throat Wild Cherry | 63736-560 | Lozenge | Over the counter monograph drugs | July 28, 2009 |
| Americaine | 63736-378 | Aerosol, spray | Over the counter monograph drugs | July 14, 2009 |
| Americaine | 63736-375 | Ointment | Over the counter monograph drugs | July 10, 2009 |
| Caldesene Baby | 63736-305 | Powder | Over the counter monograph drugs | July 7, 2009 |
| Anacin | 63736-200 | Tablet | Over the counter monograph drugs | June 25, 2009 |
| Nostrilla | 63736-730 | Spray, metered | Over the counter monograph drugs | June 8, 2009 |
| Monistat tioconazole 1 | 63736-413 | Ointment | Generic drugs (ANDA) | November 21, 2001 |
| Monistat 1 Combination Pack | 63736-013 | Kit | New drug applications (NDA) | June 29, 2001 |
| Monistat 3 3 Day | 63736-015 | Cream | New drug applications (NDA) | March 30, 1998 |
| Monistat 3 Combination Pack 3 Ovule Inserts | 63736-019 | Kit | New drug applications (NDA) | April 16, 1996 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.